Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adenovirus-mediated Herpes simplex Virus-thymidine kinase gene

EU orphan designation number: EU/3/01/083   
Active ingredient: Adenovirus-mediated Herpes simplex Virus-thymidine kinase gene
Indication: Treatment of high-grade glioma with subsequent use of ganciclovir sodium
Sponsor: Gliotherapy Limited
Sanderum House, Oakley Road, Chinnor, Oxfordshire OX39 4TW United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/02/2002 Orphan designation EMEA/OD/055/01 (2002)489 of 06/02/2002
31/01/2012 Change of name and/or address of sponsor EMEA/OD/055/01
27/02/2014 Change of name and/or address of sponsor
20/06/2016 Transfer of orphan designation EMA/OD/055/01/T/01 (2016)3838 of 16/06/2016